Role of Newer Atypical Antipsychotics in the Management of Treatment-Resistant Schizophrenia

被引：0
|
作者：
Robin A. Emsley
机构：
[1] University of Stellenbosch,Department of Psychiatry
[2] Department of Psychiatry,undefined
来源：
CNS Drugs | 2000年 / 13卷
关键词：
Schizophrenia; Clozapine; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
This article reviews the evidence of the effects of atypical antipsychotics other than clozapine in patients with schizophrenia that is resistant to treatment with conventional agents. Clozapine remains the one drug with proven efficacy in patients with severely refractory symptoms. However, while the drug is modestly effective in 30 to 70% of these patients, there are many who are either intolerant of, or unresponsive to, it.
引用
收藏
页码：409 / 420
页数：11
相关论文
共 50 条
  • [41] Efficacy of newer generation antipsychotics in the treatment of schizophrenia
    Tandon, R
    Jibson, MD
    [J]. PSYCHONEUROENDOCRINOLOGY, 2003, 28 : 9 - 26
  • [42] Use of two long-acting injectable antipsychotics for treatment-resistant schizophrenia
    Mathew, Cyriac
    Venkatesh, Sujatha A.
    Tirupati, Srinivasan
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 (11): : 1098 - 1099
  • [43] Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
    Itahashi, Takashi
    Noda, Yoshihiro
    Iwata, Yusuke
    Tarumi, Ryosuke
    Tsugawa, Sakiko
    Plitman, Eric
    Honda, Shiori
    Caravaggio, Fernando
    Kim, Julia
    Matsushita, Karin
    Gerretsen, Philip
    Uchida, Hiroyuki
    Remington, Gary
    Mimura, Masaru
    Aoki, Yuta Y.
    Graff-Guerrero, Ariel
    Nakajima, Shinichiro
    [J]. NEUROIMAGE-CLINICAL, 2021, 32
  • [44] Newer antipsychotics play an important role in the management of late-onset schizophrenia
    不详
    [J]. Drugs & Therapy Perspectives, 2000, 16 (8) : 7 - 10
  • [45] Atypical antipsychotics in the treatment of schizophrenia - Reply
    Geddes, J
    Harrison, P
    Freemantle, N
    Bebbington, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 927 - 928
  • [46] A study of enhanced management in patients with treatment-resistant schizophrenia
    Mercer, G
    Finlayson, A
    Johnstone, EC
    Murray, C
    Owens, DGC
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1997, 11 (04) : 349 - 356
  • [47] Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
    Kane, John M.
    Agid, Ofer
    Baldwin, Marjorie L.
    Howes, Oliver
    Lindenmayer, Jean-Pierre
    Marder, Stephen
    Olfson, Mark
    Potkin, Steven G.
    Correll, Christoph U.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2019, 80 (02)
  • [48] NEUROCOGNITIVE MANAGEMENT OF THE PRIMARY NEGATIVE SYMPTOMS OF SCHIZOPHRENIA: A ROLE OF ATYPICAL ANTIPSYCHOTICS
    Franza, Francesco
    Carpentieri, Gabriella
    De Guglielmo, Serena
    Fasano, Vincenzo
    Fiorentino, Nicoletta
    Perito, Mariangela
    Solomita, Barbara
    Del Buono, Gianfranco
    [J]. PSYCHIATRIA DANUBINA, 2016, 28 : S145 - S148
  • [49] The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia
    Awad, A. George
    Voruganti, Lakshmi N. P.
    [J]. CNS DRUGS, 2013, 27 (08) : 625 - 636
  • [50] The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia
    A. George Awad
    Lakshmi N. P. Voruganti
    [J]. CNS Drugs, 2013, 27 : 625 - 636
12345